Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 18:32:22 UTC
Update Date2021-09-26 23:13:57 UTC
HMDB IDHMDB0257527
Secondary Accession NumbersNone
Metabolite Identification
Common NameN-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine
DescriptionN-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-7-yl]methyl}piperidin-4-amine belongs to the class of organic compounds known as imidazo-[4,5-c]pyridines. These are organic heterocyclic compounds containing an imidazo-[4,5-c]pyridine ring system. Imidazo-[4,5-c]pyridine consists of an imidazole ring fused to a pyridine, so that the three ring nitrogen atoms are at the 1-, 2-, and 5-position, respectively. Based on a literature review very few articles have been published on N-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-7-yl]methyl}piperidin-4-amine. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC16H22N8O
Average Molecular Weight342.407
Monoisotopic Molecular Weight342.19165736
IUPAC NameN-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-7-yl]methyl}piperidin-4-amine
Traditional NameN-{[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]methyl}piperidin-4-amine
CAS Registry NumberNot Available
SMILES
CCN1C(=NC2=C1C(CNC1CCNCC1)=CN=C2)C1=NON=C1N
InChI Identifier
InChI=1S/C16H22N8O/c1-2-24-14-10(8-20-11-3-5-18-6-4-11)7-19-9-12(14)21-16(24)13-15(17)23-25-22-13/h7,9,11,18,20H,2-6,8H2,1H3,(H2,17,23)
InChI KeyMBCJUIJWPYUEBX-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as imidazo-[4,5-c]pyridines. These are organic heterocyclic compounds containing an imidazo-[4,5-c]pyridine ring system. Imidazo-[4,5-c]pyridine consists of an imidazole ring fused to a pyridine, so that the three ring nitrogen atoms are at the 1-, 2-, and 5-position, respectively.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassImidazopyridines
Sub ClassImidazo-[4,5-c]pyridines
Direct ParentImidazo-[4,5-c]pyridines
Alternative Parents
Substituents
  • Imidazo-[4,5-c]pyridine
  • 4-aminopiperidine
  • Aralkylamine
  • N-substituted imidazole
  • Piperidine
  • Pyridine
  • Imidolactam
  • Azole
  • Furazan
  • Imidazole
  • Oxadiazole
  • Heteroaromatic compound
  • Secondary aliphatic amine
  • Secondary amine
  • Oxacycle
  • Azacycle
  • Hydrocarbon derivative
  • Amine
  • Organonitrogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Primary amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP0.51ALOGPS
logP-0.41ChemAxon
logS-3.1ALOGPS
pKa (Strongest Acidic)13.54ChemAxon
pKa (Strongest Basic)10ChemAxon
Physiological Charge2ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area119.71 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity105.98 m³·mol⁻¹ChemAxon
Polarizability36.15 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+176.63230932474
DeepCCS[M-H]-174.21630932474
DeepCCS[M-2H]-208.36230932474
DeepCCS[M+Na]+184.13130932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amineCCN1C(=NC2=C1C(CNC1CCNCC1)=CN=C2)C1=NON=C1N3235.1Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amineCCN1C(=NC2=C1C(CNC1CCNCC1)=CN=C2)C1=NON=C1N3133.8Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amineCCN1C(=NC2=C1C(CNC1CCNCC1)=CN=C2)C1=NON=C1N3305.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #1CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213281.5Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #1CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213230.0Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #1CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C215538.5Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #2CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C213249.8Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #2CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C213075.8Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #2CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C215644.5Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #3CCN1C(C2=NON=C2N)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C213345.3Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #3CCN1C(C2=NON=C2N)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C213185.6Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TMS,isomer #3CCN1C(C2=NON=C2N)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C215520.6Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213218.5Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213334.0Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C214921.5Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #2CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C213237.6Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #2CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C213148.6Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #2CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C215250.4Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C213340.4Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C213256.9Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C215151.4Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #4CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C213305.5Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #4CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C213275.9Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TMS,isomer #4CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C215370.6Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C213245.9Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C213268.5Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C)=C214572.0Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #2CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C213310.8Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #2CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C213404.3Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #2CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C)CC3)=C214542.0Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C213348.7Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C213324.1Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C214973.3Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,4TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C213354.0Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,4TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C213453.7Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,4TMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C)[Si](C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C)CC3)[Si](C)(C)C)=C214374.6Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #1CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213450.9Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #1CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213450.0Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #1CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C215433.1Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #2CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C213410.4Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #2CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C213267.9Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #2CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C215602.4Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #3CCN1C(C2=NON=C2N)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C213547.6Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #3CCN1C(C2=NON=C2N)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C213390.2Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,1TBDMS,isomer #3CCN1C(C2=NON=C2N)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C215579.4Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213557.2Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C213711.9Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCNCC3)=C214807.9Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #2CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C213550.5Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #2CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C213521.0Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #2CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C215137.9Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C213687.1Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C213668.6Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C215163.8Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #4CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C213665.4Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #4CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C213668.9Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,2TBDMS,isomer #4CCN1C(C2=NON=C2N)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C215350.1Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C213660.9Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C213818.0Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCNCC3)[Si](C)(C)C(C)(C)C)=C214530.8Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #2CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C213811.7Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #2CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C213999.6Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #2CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CNC3CCN([Si](C)(C)C(C)(C)C)CC3)=C214589.0Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C213831.0Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C213900.2Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,3TBDMS,isomer #3CCN1C(C2=NON=C2N[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C214998.7Standard polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,4TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C213985.4Semi standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,4TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C214160.8Standard non polar33892256
N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine,4TBDMS,isomer #1CCN1C(C2=NON=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC2=CN=CC(CN(C3CCN([Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)=C214492.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-4195000000-8fb3adcb277ae4518c6b2021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-[[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[5,4-d]pyridin-7-yl]methyl]piperidin-4-amine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9568621
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11393719
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]